Mason Street Advisors’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-11,384
| Closed | -$107K | – | 1527 |
|
|
2020
Q3 | $107K | Sell |
11,384
-1,483
| -12% | -$13.9K | ﹤0.01% | 1450 |
|
|
2020
Q2 | $98K | Buy |
12,867
+1,054
| +9% | +$8.03K | ﹤0.01% | 1455 |
|
|
2020
Q1 | $73K | Hold |
11,813
| – | – | ﹤0.01% | 1457 |
|
|
2019
Q4 | $144K | Buy |
11,813
+302
| +3% | +$3.68K | ﹤0.01% | 1447 |
|
|
2019
Q3 | $133K | Buy |
11,511
+240
| +2% | +$2.77K | ﹤0.01% | 1435 |
|
|
2019
Q2 | $113K | Buy |
11,271
+123
| +1% | +$1.23K | ﹤0.01% | 1453 |
|
|
2019
Q1 | $144K | Buy |
11,148
+423
| +4% | +$5.46K | ﹤0.01% | 1472 |
|
|
2018
Q4 | $163K | Buy |
10,725
+511
| +5% | +$7.77K | ﹤0.01% | 1377 |
|
|
2018
Q3 | $204K | Buy |
10,214
+301
| +3% | +$6.01K | ﹤0.01% | 1366 |
|
|
2018
Q2 | $193K | Buy |
9,913
+456
| +5% | +$8.88K | ﹤0.01% | 1385 |
|
|
2018
Q1 | $191K | Buy |
9,457
+257
| +3% | +$5.19K | ﹤0.01% | 1351 |
|
|
2017
Q4 | $122K | Buy |
9,200
+263
| +3% | +$3.49K | ﹤0.01% | 1435 |
|
|
2017
Q3 | $165K | Buy |
8,937
+295
| +3% | +$5.45K | ﹤0.01% | 1362 |
|
|
2017
Q2 | $159K | Buy |
8,642
+612
| +8% | +$11.3K | ﹤0.01% | 1354 |
|
|
2017
Q1 | $181K | Buy |
8,030
+554
| +7% | +$12.5K | ﹤0.01% | 1304 |
|
|
2016
Q4 | $260K | Buy |
7,476
+445
| +6% | +$15.5K | 0.01% | 1162 |
|
|
2016
Q3 | $172K | Buy |
7,031
+271
| +4% | +$6.63K | ﹤0.01% | 1259 |
|
|
2016
Q2 | $162K | Buy |
6,760
+583
| +9% | +$14K | ﹤0.01% | 1241 |
|
|
2016
Q1 | $145K | Buy |
+6,177
| New | +$145K | ﹤0.01% | 1242 |
|